Liposomal Bupivicaine (Exparel) for Pain Control During Care of Rib Fractures
Withdrawn prior to enrolment
Phase of Trial: Phase IV
Latest Information Update: 24 Jan 2017
At a glance
- Drugs Bupivacaine (Primary)
- Indications Pain
- Focus Therapeutic Use
- 17 Jan 2017 Planned End Date changed from 1 Apr 2016 to 1 Jan 2017.
- 17 Jan 2017 Planned primary completion date changed from 1 Apr 2016 to 1 Jan 2017.
- 07 Jun 2015 Status changed from not yet recruiting to withdrawn prior to enrolment as reported by ClinicalTrials.gov.